🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 15 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/02/2013 | 40,42 | 40,79 | 40,29 | 40,71 | +1,04% | 1,25% | 17.607.343 |
| 19/02/2013 | 39,69 | 40,29 | 39,68 | 40,29 | +1,93% | 1,54% | 13.944.793 |
| 15/02/2013 | 39,56 | 39,60 | 39,35 | 39,52 | +0,56% | 0,63% | 16.326.897 |
| 14/02/2013 | 39,16 | 39,33 | 38,96 | 39,30 | +0,10% | 0,95% | 17.116.774 |
| 13/02/2013 | 39,52 | 39,59 | 39,13 | 39,27 | -0,72% | 1,16% | 16.561.858 |
| 12/02/2013 | 39,48 | 39,67 | 39,25 | 39,55 | +0,17% | 1,06% | 10.475.808 |
| 11/02/2013 | 39,30 | 39,60 | 39,21 | 39,48 | +0,49% | 1,00% | 11.959.776 |
| 08/02/2013 | 39,18 | 39,29 | 39,07 | 39,29 | +0,44% | 0,56% | 15.365.566 |
| 07/02/2013 | 39,22 | 39,41 | 39,01 | 39,12 | -0,22% | 1,02% | 16.950.666 |
| 06/02/2013 | 39,46 | 39,55 | 39,10 | 39,21 | -0,82% | 1,14% | 18.218.222 |
| 05/02/2013 | 39,17 | 39,58 | 39,06 | 39,53 | +1,42% | 1,34% | 22.330.050 |
| 04/02/2013 | 39,49 | 39,75 | 38,96 | 38,98 | -2,34% | 2,01% | 30.821.366 |
| 01/02/2013 | 40,31 | 40,79 | 39,61 | 39,91 | -3,28% | 2,94% | 39.497.024 |
| 31/01/2013 | 41,44 | 41,64 | 41,27 | 41,27 | -0,57% | 0,90% | 15.237.291 |
| 30/01/2013 | 41,66 | 41,77 | 41,47 | 41,51 | -0,37% | 0,71% | 13.280.885 |
| 29/01/2013 | 41,21 | 41,74 | 41,02 | 41,66 | +1,70% | 1,74% | 16.474.874 |
| 28/01/2013 | 41,36 | 41,51 | 40,96 | 40,96 | -1,22% | 1,32% | 12.418.800 |
| 25/01/2013 | 41,15 | 41,47 | 40,76 | 41,47 | +1,07% | 1,72% | 13.799.330 |
| 24/01/2013 | 40,98 | 41,23 | 40,96 | 41,03 | +0,42% | 0,65% | 13.096.122 |
| 23/01/2013 | 41,03 | 41,11 | 40,60 | 40,86 | -0,88% | 1,23% | 14.854.666 |
| 22/01/2013 | 40,81 | 41,24 | 40,66 | 41,22 | +0,51% | 1,43% | 12.819.765 |
| 18/01/2013 | 40,92 | 41,01 | 40,70 | 41,01 | +0,54% | 0,77% | 17.222.937 |
| 17/01/2013 | 40,85 | 40,89 | 40,59 | 40,79 | +0,49% | 0,72% | 16.255.109 |
| 16/01/2013 | 40,93 | 41,07 | 40,55 | 40,59 | -0,77% | 1,26% | 12.481.156 |
| 15/01/2013 | 41,39 | 41,55 | 40,85 | 40,91 | -1,08% | 1,68% | 12.446.677 |
| 14/01/2013 | 41,33 | 41,56 | 41,08 | 41,36 | +0,25% | 1,18% | 11.650.721 |
| 11/01/2013 | 40,75 | 41,35 | 40,75 | 41,25 | +1,05% | 1,45% | 12.722.825 |
| 10/01/2013 | 40,91 | 41,17 | 40,79 | 40,82 | +0,45% | 0,93% | 13.593.084 |
| 09/01/2013 | 40,45 | 40,70 | 40,27 | 40,64 | +0,97% | 1,06% | 10.556.609 |
| 08/01/2013 | 40,31 | 40,73 | 40,25 | 40,25 | +0,14% | 1,21% | 15.458.943 |